JP2012097034A5 - - Google Patents

Download PDF

Info

Publication number
JP2012097034A5
JP2012097034A5 JP2010246112A JP2010246112A JP2012097034A5 JP 2012097034 A5 JP2012097034 A5 JP 2012097034A5 JP 2010246112 A JP2010246112 A JP 2010246112A JP 2010246112 A JP2010246112 A JP 2010246112A JP 2012097034 A5 JP2012097034 A5 JP 2012097034A5
Authority
JP
Japan
Prior art keywords
composition
hipokisanchi
autoinducer
creatine
taurine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010246112A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012097034A (ja
JP5756614B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2010246112A priority Critical patent/JP5756614B2/ja
Priority claimed from JP2010246112A external-priority patent/JP5756614B2/ja
Publication of JP2012097034A publication Critical patent/JP2012097034A/ja
Publication of JP2012097034A5 publication Critical patent/JP2012097034A5/ja
Application granted granted Critical
Publication of JP5756614B2 publication Critical patent/JP5756614B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010246112A 2010-11-02 2010-11-02 オートインデューサー−2阻害剤、並びに齲蝕病の予防及び/又は治療剤 Active JP5756614B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010246112A JP5756614B2 (ja) 2010-11-02 2010-11-02 オートインデューサー−2阻害剤、並びに齲蝕病の予防及び/又は治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010246112A JP5756614B2 (ja) 2010-11-02 2010-11-02 オートインデューサー−2阻害剤、並びに齲蝕病の予防及び/又は治療剤

Publications (3)

Publication Number Publication Date
JP2012097034A JP2012097034A (ja) 2012-05-24
JP2012097034A5 true JP2012097034A5 (fr) 2013-10-31
JP5756614B2 JP5756614B2 (ja) 2015-07-29

Family

ID=46389377

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010246112A Active JP5756614B2 (ja) 2010-11-02 2010-11-02 オートインデューサー−2阻害剤、並びに齲蝕病の予防及び/又は治療剤

Country Status (1)

Country Link
JP (1) JP5756614B2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2745836B1 (fr) * 2012-12-18 2016-08-31 Sunstar Suisse SA Composition orale topique destinée à soulager les symptômes de la bouche sèche et traiter les ulcères buccaux
EP3405193B1 (fr) 2016-01-19 2022-03-23 AchromaZ Pte. Ltd. Composition cosmétique et son utilisation servant à réguler la qualité de la peau
CN108042384B (zh) * 2018-01-08 2020-07-10 弘美制药(中国)有限公司 一种具有口腔清洁和治疗功效的组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE238049T1 (de) * 1998-07-28 2003-05-15 Synthes Ag Verwendung von kreatinsubstanzen zur behandlung von knochen- und knorpelzellen und geweben
DE19841385A1 (de) * 1998-09-10 2000-03-16 Sueddeutsche Kalkstickstoff Verwendung von Kreatin und/oder Kreatin-derivaten als Feuchthaltemittel in kosmetischen Zubereitungen
JP2010159219A (ja) * 2009-01-07 2010-07-22 Kao Corp Ai−2阻害剤

Similar Documents

Publication Publication Date Title
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
JP2015523407A5 (fr)
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
BR112013032122A2 (pt) liberação modificada de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)fenil] benzamida solubilizada usando ácidos orgânicos
JP2015038135A5 (fr)
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
EA200901423A1 (ru) Бензимидазолы и содержащие их фармацевтические композиции
JP2007238598A5 (fr)
BRPI0814666A2 (pt) composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
BRPI0807285A2 (pt) "composição, método para preparar composição farmacêutica, forma unitária de dosagem, método para admnistrar um agente biologicamente ativo a um animal necessitando o agente, método para aumentar a biodisponibilidade de um agente biologicamente ativo, método para preparar uma composição e composto"
IL222578A0 (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
WO2011056240A3 (fr) Compositions pharmaceutiques et formes galéniques orales d'un promédicament de lévodopa et procédés d'utilisation
PT2459153E (pt) Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar
ATE505203T1 (de) Pharmazeutische kombination aus aliskiren und valsartan
WO2011093815A3 (fr) Compositions pharmaceutiques comprenant du formotérol et du mométasone
JP2012097034A5 (fr)
JP2012097036A5 (fr)
JP2013032308A5 (fr)
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
MX338975B (es) Composicion farmaceutica que contiene sales de citrato y bicarbonato, y su uso para el tratamiento de la cistinuria.
CY1111361T1 (el) Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια
RU2011143735A (ru) Средство для отбеливания кожи и косметический способ отбеливания кожи
JP2017530142A5 (fr)
WO2011161223A3 (fr) Formes pharmaceutiques à usage oral comprenant de la lercanidipine et de l'énalapril et leurs sels pharmaceutiquement acceptables